Ask OpenScientist

Ask a research question about Splenic artery aneurysm. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Definitions
5
Pathophys.
6
Phenotypes
9
Pathograph
3
Treatments
2
Trials
1
Deep Research
📘

Definitions

1
Visceral splenic arterial aneurysm
A true splenic artery aneurysm is an aneurysmal dilatation of the splenic artery and is distinct from splenic artery pseudoaneurysm, which is usually caused by local wall disruption and carries a higher rupture-risk management threshold.
CASE_DEFINITION Clinical and imaging definition of splenic artery aneurysm
Show evidence (2 references)
PMID:31839799 SUPPORT Human Clinical
"True splenic artery aneurysms (SAA) are a rare, but potentially fatal, pathology."
The review defines true SAA as a rare but clinically important splenic arterial aneurysm entity.
PMID:39407852 SUPPORT Human Clinical
"Giant splenic artery aneurysms (SAAs) and pseudoaneurysms (SAPs) represent rare conditions, characterized by a diameter greater than or equal to 5 cm."
The systematic review supports the aneurysm/pseudoaneurysm distinction and the clinically important giant-lesion size category.

Pathophysiology

5
Splenic arterial wall remodeling
Multifactorial splenic arterial wall remodeling weakens the vessel wall and permits focal aneurysmal dilatation. The structured evidence base for isolated true SAA is mostly clinical, so this node represents the shared vessel-wall failure endpoint rather than a single molecular cause.
vascular smooth muscle cell link endothelial cell link fibroblast link
blood vessel remodeling link ⚠ ABNORMAL extracellular matrix organization link ⚠ ABNORMAL
splenic artery link tunica media link
Show evidence (1 reference)
PMID:31839799 PARTIAL Human Clinical
"There are multiple etiologies and it is believed that hormonal influences and changes in portal flow during gestation play an important role in development of SAA."
The review supports a multifactorial vessel-wall and hemodynamic model, while the abstract does not define a single cellular mechanism.
Portal-hypertensive splenic hyperkinetic flow
Portal hypertension can increase splenic arterial diameter and flow, creating a hyperkinetic splenic circulation that increases mechanical stress on the splenic artery and favors aneurysm formation or intervention.
endothelial cell link vascular smooth muscle cell link
response to mechanical stimulus link ↑ INCREASED blood vessel remodeling link ⚠ ABNORMAL
splenic artery link
Show evidence (1 reference)
PMID:1483666 SUPPORT Human Clinical
"In the portal hypertensive patients with splenic artery aneurysms, the splenic artery was larger (p < 0.05) and the splenic arterial flow greater (p < 0.05), and these patients were in a more hyperkinetic state, than were those with no splenic artery aneurysm."
This case-control angiographic study directly links portal hypertension with increased splenic artery size and flow in SAA patients.
Tortuous splenic artery hemodynamic stress
Tortuous splenic artery geometry may concentrate hemodynamic forces and correlate with aneurysm formation and dilatation, especially in female patients.
endothelial cell link vascular smooth muscle cell link
response to mechanical stimulus link ↑ INCREASED
splenic artery link
Show evidence (2 references)
PMID:29363319 SUPPORT Human Clinical
"Background Considering the unique characteristics of splenic artery aneurysms, we hypothesized that hemodynamic forces could play an important role in splenic artery aneurysm formation and that splenic artery geometry should be correlated with aneurysm development."
This study frames tortuous splenic artery geometry as a hemodynamic contributor to SAA formation.
PMID:29363319 SUPPORT Human Clinical
"Conclusion Females with a tortuous splenic artery may have an increased risk of aneurysm formation."
The abstract conclusion supports tortuosity as a sex-linked geometric risk context for SAA.
Pregnancy-associated portal-flow and hormonal stress
Pregnancy is a high-risk physiologic context for SAA because gestational hormonal influences and portal-flow changes can interact with pre-existing wall vulnerability, and rupture has very high maternal and fetal mortality.
vascular smooth muscle cell link
blood vessel remodeling link ⚠ ABNORMAL
splenic artery link
Show evidence (2 references)
PMID:31839799 SUPPORT Human Clinical
"Among pregnant patients, mortality after rupture is 65-75%, with fetal mortality exceeding 90%."
The review quantifies the exceptionally severe pregnancy-associated rupture prognosis.
PMID:31839799 PARTIAL Human Clinical
"There are multiple etiologies and it is believed that hormonal influences and changes in portal flow during gestation play an important role in development of SAA."
This supports pregnancy-related hormonal and portal-flow mechanisms while preserving the review's wording that the mechanism is believed rather than experimentally proven.
Aneurysm rupture and hemorrhage
Rupture of a splenic artery aneurysm causes internal bleeding that may present with abdominal pain, hematoma, gastrointestinal bleeding, hypotension, syncope, or hypovolemic shock.
splenic artery link
Show evidence (2 references)
PMID:38249169 SUPPORT Human Clinical
"The patient presented in the emergency department with abdominal pain, nausea, and vomiting, followed by syncope."
The case report supports the symptomatic rupture presentation.
PMID:35915344 SUPPORT Human Clinical
"He developed upper gastrointestinal (UGI) bleeding and hypovolemic shock."
This case report directly supports bleeding and shock as rupture consequences.

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Splenic artery aneurysm Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.

Phenotypes

6
Blood 1
Gastrointestinal hemorrhage Gastrointestinal hemorrhage (HP:0002239)
Show evidence (1 reference)
PMID:35915344 SUPPORT Human Clinical
"This report shows that splenic artery aneurysm can cause UGI bleeding."
The case-report conclusion directly supports upper gastrointestinal bleeding as a possible complication.
Cardiovascular 2
Splenic artery aneurysm Vascular dilatation (HP:0002617)
Show evidence (1 reference)
PMID:31839799 SUPPORT Human Clinical
"True splenic artery aneurysms (SAA) are a rare, but potentially fatal, pathology."
The review directly defines true SAA as a rare and potentially fatal aneurysm pathology.
Hypovolemic shock Hypovolemic shock (HP:0031274)
Show evidence (1 reference)
PMID:35915344 SUPPORT Human Clinical
"He developed upper gastrointestinal (UGI) bleeding and hypovolemic shock."
The case report directly documents hypovolemic shock from ruptured SAA.
Constitutional 1
Abdominal pain Abdominal pain (HP:0002027)
Show evidence (2 references)
PMID:39407852 SUPPORT Human Clinical
"The most frequently described symptom was pain (59.76%)."
The systematic review identifies pain as the most common symptom among giant SAA/SAP cases.
PMID:38249169 SUPPORT Human Clinical
"The patient presented in the emergency department with abdominal pain, nausea, and vomiting, followed by syncope."
This rupture case demonstrates abdominal pain at acute presentation.
Other 2
Asymptomatic incidental presentation
Show evidence (1 reference)
PMID:30496903 SUPPORT Human Clinical
"Thirty-nine (92.9%) patients were asymptomatic, and 3 (7.1%) patients were symptomatic."
This intact-SAA intervention cohort supports frequent asymptomatic presentation among intact aneurysms.
Hematoma after rupture Internal hemorrhage (HP:0011029)
Show evidence (1 reference)
PMID:38249169 SUPPORT Human Clinical
"A contrast-enhanced CT scan was performed and showed a splenic artery aneurysm measuring 40 × 35 mm surrounded by a hematoma."
The CT finding of a hematoma surrounding the ruptured aneurysm supports internal hemorrhage.
💊

Treatments

3
Endovascular coil embolization
Action: embolization therapy Ontology label: Embolization Therapy NCIT:C15230
Coil embolization excludes the aneurysm or parent artery from flow and is a common first-line approach for intact anatomically suitable SAA.
Mechanism Target:
INHIBITS Splenic arterial wall remodeling — Endovascular exclusion reduces flow into the aneurysm sac and mitigates rupture risk.
Target Phenotypes: splenic artery aneurysm
Show evidence (2 references)
PMID:30496903 SUPPORT Human Clinical
"In the endovascular group, the exclusive means was embolization with coils."
The intact-SAA cohort directly describes coil embolization as the endovascular approach used.
PMID:30496903 SUPPORT Human Clinical
"Endovascular repair is less invasive accompanied with an obvious decrease in surgery time and rapid recovery with a short hospital time."
The cohort conclusion supports the perioperative recovery advantage of endovascular repair.
Open surgical repair, ligation, resection, or splenectomy
Action: surgical procedure MAXO:0000004
Open repair includes aneurysm ligation or resection, sometimes with splenectomy, arterial reconstruction, or distal pancreatic resection, especially for rupture, giant lesions, unfavorable anatomy, or instability.
Mechanism Target:
INHIBITS Aneurysm rupture and hemorrhage — Open ligation, resection, and splenectomy control bleeding and remove the aneurysm when rupture or anatomy requires surgery.
Target Phenotypes: splenic artery aneurysm
Show evidence (2 references)
PMID:30496903 SUPPORT Human Clinical
"In the surgical group, the common methods used were splenic artery aneurysm resection (9 patients), followed by splenic artery aneurysms resection and splenectomy (6 patients), splenic artery aneurysm resection and arterial reconstruction with end-to-end anastomosis (3 patients), and..."
The cohort enumerates open/laparoscopic surgical approaches for intact SAA.
PMID:38249169 SUPPORT Human Clinical
"The patient was submitted to emergency laparotomy with ligation of the splenic artery, aneurysm resection, and splenectomy."
This rupture case supports emergency open surgical control with ligation, aneurysm resection, and splenectomy.
Selective surveillance of small stable intact true aneurysms
Selected intact asymptomatic true SAAs can be monitored rather than repaired immediately when high-risk features such as childbearing potential, symptoms, growth, large size, or pseudoaneurysm are absent.
Target Phenotypes: splenic artery aneurysm
Show evidence (2 references)
PMID:12089631 SUPPORT Human Clinical
"From analysis of the patient data we concluded that although SAAs may rupture, not all intact aneurysms need intervention."
This supports selective nonintervention for carefully selected intact aneurysms.
PMID:32201007 SUPPORT Human Clinical
"They include evidence-based size thresholds for repair of aneurysms of the renal arteries, splenic artery, celiac artery, and hepatic artery, among others."
The SVS guideline abstract supports threshold-based rather than universal repair of visceral aneurysms including SAA.
🌍

Environmental Factors

4
Portal hypertension
Portal hypertension is a high-risk clinical context for SAA, associated with hyperkinetic splenic flow, larger aneurysm diameter at diagnosis, and greater intervention rates.
Show evidence (2 references)
PMID:1483666 SUPPORT Human Clinical
"The study suggests that splenic artery aneurysms in cases of portal hypertension may be the consequence of a hyperkinetic state in the spleen."
This provides a mechanistic association between portal hypertension and SAA through splenic hyperkinesis.
PMID:39009114 SUPPORT Human Clinical
"Splenic artery aneurysms (SAAs) are rare but seem to have higher incidence in patients with portal hypertension (PH)."
The 2024 cohort paper identifies portal hypertension as an incidence-risk context.
Liver transplantation and parenchymal liver disease context
SAA is enriched in liver-transplant populations with portal hypertension and parenchymal liver disease, making pre- or peri-transplant detection and management clinically important.
Show evidence (1 reference)
PMID:9382977 SUPPORT Human Clinical
"In patients without portal hypertension no aneurysms were identified, whereas in 16% of the patients with portal hypertension aneurysms were found (p<0.001)."
The liver-transplant angiography series supports the portal-hypertension association in a transplant-relevant cohort.
Pregnancy and childbearing potential
Pregnancy and childbearing potential are high-risk contexts because rupture during pregnancy carries very high maternal and fetal mortality.
Show evidence (2 references)
PMID:31839799 SUPPORT Human Clinical
"True aneurysms account for 60% of SAA and affect four times as many women as men, generally related to increased incidental or symptomatic findings that coincide with use of ultrasonography in pregnancy."
The review supports female and pregnancy-linked detection/risk context.
PMID:31839799 SUPPORT Human Clinical
"Among pregnant patients, mortality after rupture is 65-75%, with fetal mortality exceeding 90%."
This quantifies the high-consequence pregnancy rupture risk.
Essential hypertension
Essential hypertension has been reported as a significant risk factor in non-portal-hypertension SAA patients.
Show evidence (1 reference)
PMID:10549737 SUPPORT Human Clinical
"In patients without a history of PHTN (n = 12), essential hypertension was a significant risk factor (p < 0.001) for development of SAA."
This treated-SAA cohort identifies essential hypertension as a risk factor outside portal hypertension.
🔬

Clinical Trials

2
NCT07053605 RECRUITING
Single-group interventional study evaluating laparoscopic resection of SAA with spleen preservation and post-treatment immune and portal/splenic hemodynamic markers.
Target Phenotypes: splenic artery aneurysm
Show evidence (1 reference)
clinicaltrials:NCT07053605 SUPPORT Human Clinical
"In this study, researchers examined the changes in related indicators such as immune function, splenic vein,proper hepatic artery, and portal venous hemodynamics following laparoscopic resection of a splenic artery aneurysm."
The trial summary directly describes laparoscopic SAA resection with spleen preservation and hemodynamic/immune follow-up.
NCT01387828 COMPLETED
Randomized comparison of open versus laparoscopic surgical management of splenic artery aneurysms.
Target Phenotypes: splenic artery aneurysm
Show evidence (1 reference)
clinicaltrials:NCT01387828 SUPPORT Human Clinical
"The purpose of this study is compare two different surgical treatments of splenic artery aneurysms: open and laparoscopic approach."
The trial summary supports the existence of a completed open-vs-laparoscopic SAA surgical comparison.
{ }

Source YAML

click to show
name: Splenic artery aneurysm
creation_date: "2026-05-06T18:59:54Z"
updated_date: "2026-05-06T19:28:47Z"
category: Complex
description: >-
  Splenic artery aneurysm is a visceral arterial aneurysm involving focal
  dilatation of the splenic artery. Most intact true aneurysms are discovered
  incidentally, but risk stratification changes substantially with portal
  hypertension, pregnancy or childbearing potential, aneurysm growth or large
  size, symptoms, pseudoaneurysm biology, and rupture.
disease_term:
  preferred_term: splenic artery aneurysm
  term:
    id: MONDO:0001856
    label: splenic artery aneurysm
synonyms:
- SAA
- Splenic aneurysm
- True splenic artery aneurysm
parents:
- Arterial disorder
- Vascular disorder
definitions:
- name: Visceral splenic arterial aneurysm
  definition_type: CASE_DEFINITION
  description: >-
    A true splenic artery aneurysm is an aneurysmal dilatation of the splenic
    artery and is distinct from splenic artery pseudoaneurysm, which is usually
    caused by local wall disruption and carries a higher rupture-risk management
    threshold.
  scope: Clinical and imaging definition of splenic artery aneurysm
  evidence:
  - reference: PMID:31839799
    reference_title: "Splenic aneurysms: natural history and treatment techniques."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      True splenic artery aneurysms (SAA) are a rare, but potentially fatal,
      pathology.
    explanation: >-
      The review defines true SAA as a rare but clinically important splenic
      arterial aneurysm entity.
  - reference: PMID:39407852
    reference_title: "The Definition, Diagnosis, and Management of Giant Splenic Artery Aneurysms and Pseudoaneurysms: A Systematic Review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Giant splenic artery aneurysms (SAAs) and pseudoaneurysms (SAPs)
      represent rare conditions, characterized by a diameter greater than or
      equal to 5 cm.
    explanation: >-
      The systematic review supports the aneurysm/pseudoaneurysm distinction and
      the clinically important giant-lesion size category.
progression:
- phase: Incidental intact aneurysm
  age_range: Mostly adult detection in available cohorts
  notes: >-
    Many intact SAAs are detected incidentally and can grow slowly, so
    observation may be appropriate for selected small, stable, asymptomatic true
    aneurysms outside high-risk contexts.
  evidence:
  - reference: PMID:12089631
    reference_title: "Splenic artery aneurysms: two decades experience at Mayo clinic."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Growth rates of SAA are slow and growth is infrequent.
    explanation: >-
      This Mayo Clinic series supports slow growth as a common natural-history
      pattern for intact SAA.
- phase: Rupture and hemorrhagic emergency
  age_range: Any age with SAA, with especially high concern in pregnancy and portal hypertension
  notes: >-
    Rupture converts a usually silent vascular lesion into an abdominal or
    gastrointestinal hemorrhage emergency with shock and high mortality risk.
  evidence:
  - reference: PMID:38249169
    reference_title: Spontaneous Rupture of Splenic Artery Aneurysm.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Splenic artery aneurysms are rare and usually asymptomatic, with a high
      risk of mortality once they get ruptured.
    explanation: >-
      This case-report abstract summarizes the high-risk transition from
      asymptomatic SAA to rupture-associated mortality.
pathophysiology:
- name: Splenic arterial wall remodeling
  description: >-
    Multifactorial splenic arterial wall remodeling weakens the vessel wall and
    permits focal aneurysmal dilatation. The structured evidence base for
    isolated true SAA is mostly clinical, so this node represents the shared
    vessel-wall failure endpoint rather than a single molecular cause.
  cell_types:
  - preferred_term: vascular smooth muscle cell
    term:
      id: CL:0000359
      label: vascular associated smooth muscle cell
  - preferred_term: endothelial cell
    term:
      id: CL:0000115
      label: endothelial cell
  - preferred_term: fibroblast
    term:
      id: CL:0000057
      label: fibroblast
  locations:
  - preferred_term: splenic artery
    term:
      id: UBERON:0001194
      label: splenic artery
  - preferred_term: tunica media
    term:
      id: UBERON:0002522
      label: tunica media
  biological_processes:
  - preferred_term: blood vessel remodeling
    modifier: ABNORMAL
    term:
      id: GO:0001974
      label: blood vessel remodeling
  - preferred_term: extracellular matrix organization
    modifier: ABNORMAL
    term:
      id: GO:0030198
      label: extracellular matrix organization
  evidence:
  - reference: PMID:31839799
    reference_title: "Splenic aneurysms: natural history and treatment techniques."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      There are multiple etiologies and it is believed that hormonal influences
      and changes in portal flow during gestation play an important role in
      development of SAA.
    explanation: >-
      The review supports a multifactorial vessel-wall and hemodynamic model,
      while the abstract does not define a single cellular mechanism.
  downstream:
  - target: Aneurysm rupture and hemorrhage
    description: Loss of wall integrity can progress from dilatation to rupture with hematoma, gastrointestinal bleeding, or shock.
    causal_link_type: DIRECT
- name: Portal-hypertensive splenic hyperkinetic flow
  description: >-
    Portal hypertension can increase splenic arterial diameter and flow,
    creating a hyperkinetic splenic circulation that increases mechanical stress
    on the splenic artery and favors aneurysm formation or intervention.
  cell_types:
  - preferred_term: endothelial cell
    term:
      id: CL:0000115
      label: endothelial cell
  - preferred_term: vascular smooth muscle cell
    term:
      id: CL:0000359
      label: vascular associated smooth muscle cell
  locations:
  - preferred_term: splenic artery
    term:
      id: UBERON:0001194
      label: splenic artery
  biological_processes:
  - preferred_term: response to mechanical stimulus
    modifier: INCREASED
    term:
      id: GO:0009612
      label: response to mechanical stimulus
  - preferred_term: blood vessel remodeling
    modifier: ABNORMAL
    term:
      id: GO:0001974
      label: blood vessel remodeling
  evidence:
  - reference: PMID:1483666
    reference_title: Splenic hyperkinetic state and splenic artery aneurysm in portal hypertension.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In the portal hypertensive patients with splenic artery aneurysms, the
      splenic artery was larger (p < 0.05) and the splenic arterial flow greater
      (p < 0.05), and these patients were in a more hyperkinetic state, than
      were those with no splenic artery aneurysm.
    explanation: >-
      This case-control angiographic study directly links portal hypertension
      with increased splenic artery size and flow in SAA patients.
  downstream:
  - target: Splenic arterial wall remodeling
    description: Increased flow and wall stress can drive remodeling of the splenic arterial wall.
    causal_link_type: DIRECT
- name: Tortuous splenic artery hemodynamic stress
  description: >-
    Tortuous splenic artery geometry may concentrate hemodynamic forces and
    correlate with aneurysm formation and dilatation, especially in female
    patients.
  cell_types:
  - preferred_term: endothelial cell
    term:
      id: CL:0000115
      label: endothelial cell
  - preferred_term: vascular smooth muscle cell
    term:
      id: CL:0000359
      label: vascular associated smooth muscle cell
  locations:
  - preferred_term: splenic artery
    term:
      id: UBERON:0001194
      label: splenic artery
  biological_processes:
  - preferred_term: response to mechanical stimulus
    modifier: INCREASED
    term:
      id: GO:0009612
      label: response to mechanical stimulus
  evidence:
  - reference: PMID:29363319
    reference_title: Morphological analysis using geometric parameters for splenic aneurysms.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Background Considering the unique characteristics of splenic artery
      aneurysms, we hypothesized that hemodynamic forces could play an important
      role in splenic artery aneurysm formation and that splenic artery geometry
      should be correlated with aneurysm development.
    explanation: >-
      This study frames tortuous splenic artery geometry as a hemodynamic
      contributor to SAA formation.
  - reference: PMID:29363319
    reference_title: Morphological analysis using geometric parameters for splenic aneurysms.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Conclusion Females with a tortuous splenic artery may have an increased
      risk of aneurysm formation.
    explanation: >-
      The abstract conclusion supports tortuosity as a sex-linked geometric
      risk context for SAA.
  downstream:
  - target: Splenic arterial wall remodeling
    description: Local geometry-driven stress can promote focal dilatation.
    causal_link_type: DIRECT
- name: Pregnancy-associated portal-flow and hormonal stress
  description: >-
    Pregnancy is a high-risk physiologic context for SAA because gestational
    hormonal influences and portal-flow changes can interact with pre-existing
    wall vulnerability, and rupture has very high maternal and fetal mortality.
  cell_types:
  - preferred_term: vascular smooth muscle cell
    term:
      id: CL:0000359
      label: vascular associated smooth muscle cell
  locations:
  - preferred_term: splenic artery
    term:
      id: UBERON:0001194
      label: splenic artery
  biological_processes:
  - preferred_term: blood vessel remodeling
    modifier: ABNORMAL
    term:
      id: GO:0001974
      label: blood vessel remodeling
  evidence:
  - reference: PMID:31839799
    reference_title: "Splenic aneurysms: natural history and treatment techniques."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Among pregnant patients, mortality after rupture is 65-75%, with fetal
      mortality exceeding 90%.
    explanation: >-
      The review quantifies the exceptionally severe pregnancy-associated
      rupture prognosis.
  - reference: PMID:31839799
    reference_title: "Splenic aneurysms: natural history and treatment techniques."
    supports: PARTIAL
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      There are multiple etiologies and it is believed that hormonal influences
      and changes in portal flow during gestation play an important role in
      development of SAA.
    explanation: >-
      This supports pregnancy-related hormonal and portal-flow mechanisms while
      preserving the review's wording that the mechanism is believed rather than
      experimentally proven.
  downstream:
  - target: Aneurysm rupture and hemorrhage
    description: Pregnancy-related hemodynamic and hormonal stress increases concern for rupture.
    causal_link_type: DIRECT
- name: Aneurysm rupture and hemorrhage
  description: >-
    Rupture of a splenic artery aneurysm causes internal bleeding that may
    present with abdominal pain, hematoma, gastrointestinal bleeding,
    hypotension, syncope, or hypovolemic shock.
  locations:
  - preferred_term: splenic artery
    term:
      id: UBERON:0001194
      label: splenic artery
  evidence:
  - reference: PMID:38249169
    reference_title: Spontaneous Rupture of Splenic Artery Aneurysm.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The patient presented in the emergency department with abdominal pain,
      nausea, and vomiting, followed by syncope.
    explanation: >-
      The case report supports the symptomatic rupture presentation.
  - reference: PMID:35915344
    reference_title: Giant splenic artery aneurysm rupture into the stomach that was successfully managed with emergency distal pancreatectomy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      He developed upper gastrointestinal (UGI) bleeding and hypovolemic shock.
    explanation: >-
      This case report directly supports bleeding and shock as rupture
      consequences.
phenotypes:
- category: Cardiovascular
  name: Splenic artery aneurysm
  diagnostic: true
  description: >-
    The defining finding is aneurysmal dilatation of the splenic artery,
    detected by vascular imaging, angiography, operation, or pathology.
  phenotype_term:
    preferred_term: splenic artery aneurysm
    term:
      id: HP:0002617
      label: Vascular dilatation
  evidence:
  - reference: PMID:31839799
    reference_title: "Splenic aneurysms: natural history and treatment techniques."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      True splenic artery aneurysms (SAA) are a rare, but potentially fatal,
      pathology.
    explanation: >-
      The review directly defines true SAA as a rare and potentially fatal
      aneurysm pathology.
- category: Constitutional
  name: Asymptomatic incidental presentation
  description: >-
    Many intact true SAAs are found incidentally before rupture or other
    complication.
  evidence:
  - reference: PMID:30496903
    reference_title: Endovascular and Surgical Management of Intact Splenic Artery Aneurysm.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Thirty-nine (92.9%) patients were asymptomatic, and 3 (7.1%) patients were
      symptomatic.
    explanation: >-
      This intact-SAA intervention cohort supports frequent asymptomatic
      presentation among intact aneurysms.
- category: Gastrointestinal
  name: Abdominal pain
  description: >-
    Symptomatic SAA, especially giant or ruptured lesions, can present with
    abdominal, epigastric, or left upper quadrant pain.
  phenotype_term:
    preferred_term: Abdominal pain
    term:
      id: HP:0002027
      label: Abdominal pain
  evidence:
  - reference: PMID:39407852
    reference_title: "The Definition, Diagnosis, and Management of Giant Splenic Artery Aneurysms and Pseudoaneurysms: A Systematic Review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The most frequently described symptom was pain (59.76%).
    explanation: >-
      The systematic review identifies pain as the most common symptom among
      giant SAA/SAP cases.
  - reference: PMID:38249169
    reference_title: Spontaneous Rupture of Splenic Artery Aneurysm.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The patient presented in the emergency department with abdominal pain,
      nausea, and vomiting, followed by syncope.
    explanation: >-
      This rupture case demonstrates abdominal pain at acute presentation.
- category: Gastrointestinal
  name: Gastrointestinal hemorrhage
  description: >-
    Rare rupture into the stomach or gastrointestinal tract can cause upper
    gastrointestinal bleeding.
  phenotype_term:
    preferred_term: Gastrointestinal hemorrhage
    term:
      id: HP:0002239
      label: Gastrointestinal hemorrhage
  evidence:
  - reference: PMID:35915344
    reference_title: Giant splenic artery aneurysm rupture into the stomach that was successfully managed with emergency distal pancreatectomy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This report shows that splenic artery aneurysm can cause UGI bleeding.
    explanation: >-
      The case-report conclusion directly supports upper gastrointestinal
      bleeding as a possible complication.
- category: Cardiovascular
  name: Hypovolemic shock
  severity: SEVERE
  description: >-
    Rupture-related blood loss can produce hypovolemic shock.
  phenotype_term:
    preferred_term: Hypovolemic shock
    term:
      id: HP:0031274
      label: Hypovolemic shock
  evidence:
  - reference: PMID:35915344
    reference_title: Giant splenic artery aneurysm rupture into the stomach that was successfully managed with emergency distal pancreatectomy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      He developed upper gastrointestinal (UGI) bleeding and hypovolemic shock.
    explanation: >-
      The case report directly documents hypovolemic shock from ruptured SAA.
- category: Cardiovascular
  name: Hematoma after rupture
  description: >-
    Rupture may be visible on contrast CT as peri-aneurysmal hematoma or active
    contrast extravasation.
  phenotype_term:
    preferred_term: Internal hemorrhage
    term:
      id: HP:0011029
      label: Internal hemorrhage
  evidence:
  - reference: PMID:38249169
    reference_title: Spontaneous Rupture of Splenic Artery Aneurysm.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A contrast-enhanced CT scan was performed and showed a splenic artery
      aneurysm measuring 40 × 35 mm surrounded by a hematoma.
    explanation: >-
      The CT finding of a hematoma surrounding the ruptured aneurysm supports
      internal hemorrhage.
environmental:
- name: Portal hypertension
  presence: Associated
  description: >-
    Portal hypertension is a high-risk clinical context for SAA, associated
    with hyperkinetic splenic flow, larger aneurysm diameter at diagnosis, and
    greater intervention rates.
  effect: Increased SAA formation risk and higher-risk management context
  evidence:
  - reference: PMID:1483666
    reference_title: Splenic hyperkinetic state and splenic artery aneurysm in portal hypertension.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The study suggests that splenic artery aneurysms in cases of portal
      hypertension may be the consequence of a hyperkinetic state in the spleen.
    explanation: >-
      This provides a mechanistic association between portal hypertension and
      SAA through splenic hyperkinesis.
  - reference: PMID:39009114
    reference_title: Comparison of Splenic Artery Aneurysms in Patients with and without Portal Hypertension.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Splenic artery aneurysms (SAAs) are rare but seem to have higher incidence
      in patients with portal hypertension (PH).
    explanation: >-
      The 2024 cohort paper identifies portal hypertension as an incidence-risk
      context.
- name: Liver transplantation and parenchymal liver disease context
  presence: Associated
  description: >-
    SAA is enriched in liver-transplant populations with portal hypertension and
    parenchymal liver disease, making pre- or peri-transplant detection and
    management clinically important.
  effect: Higher prevalence and rupture concern in transplant populations
  evidence:
  - reference: PMID:9382977
    reference_title: Splenic artery aneurysms in liver transplant patients. Liver Transplant Group.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In patients without portal hypertension no aneurysms were identified,
      whereas in 16% of the patients with portal hypertension aneurysms were
      found (p<0.001).
    explanation: >-
      The liver-transplant angiography series supports the portal-hypertension
      association in a transplant-relevant cohort.
- name: Pregnancy and childbearing potential
  presence: Associated
  description: >-
    Pregnancy and childbearing potential are high-risk contexts because rupture
    during pregnancy carries very high maternal and fetal mortality.
  effect: Lower threshold for repair and heightened rupture-risk concern
  evidence:
  - reference: PMID:31839799
    reference_title: "Splenic aneurysms: natural history and treatment techniques."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      True aneurysms account for 60% of SAA and affect four times as many women
      as men, generally related to increased incidental or symptomatic findings
      that coincide with use of ultrasonography in pregnancy.
    explanation: >-
      The review supports female and pregnancy-linked detection/risk context.
  - reference: PMID:31839799
    reference_title: "Splenic aneurysms: natural history and treatment techniques."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Among pregnant patients, mortality after rupture is 65-75%, with fetal
      mortality exceeding 90%.
    explanation: >-
      This quantifies the high-consequence pregnancy rupture risk.
- name: Essential hypertension
  presence: Associated
  description: >-
    Essential hypertension has been reported as a significant risk factor in
    non-portal-hypertension SAA patients.
  effect: Increased SAA development risk in non-portal-hypertension patients
  evidence:
  - reference: PMID:10549737
    reference_title: "Management of splenic artery aneurysms: the significance of portal and essential hypertension."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In patients without a history of PHTN (n = 12), essential hypertension was
      a significant risk factor (p < 0.001) for development of SAA.
    explanation: >-
      This treated-SAA cohort identifies essential hypertension as a risk factor
      outside portal hypertension.
diagnosis:
- name: Contrast-enhanced CT angiography
  description: >-
    Contrast CT/CTA is central for identifying SAA size, location, hematoma,
    active extravasation, and treatment anatomy.
  results: Splenic artery aneurysm size, location, hematoma, and active extravasation
  evidence:
  - reference: PMID:39407852
    reference_title: "The Definition, Diagnosis, and Management of Giant Splenic Artery Aneurysms and Pseudoaneurysms: A Systematic Review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The CT scan was the most utilized imaging study (80.49%).
    explanation: >-
      The 2024 systematic review supports CT as the dominant diagnostic imaging
      modality in giant SAA/SAP cases.
  - reference: PMID:38249169
    reference_title: Spontaneous Rupture of Splenic Artery Aneurysm.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A contrast-enhanced CT scan was performed and showed a splenic artery
      aneurysm measuring 40 × 35 mm surrounded by a hematoma.
    explanation: >-
      This rupture case shows contrast-enhanced CT detecting the aneurysm and
      adjacent hemorrhage.
- name: Angiographic and ultrasound assessment
  description: >-
    Angiography can define splenic artery anatomy and enable endovascular
    therapy, while ultrasound may detect SAA incidentally or in pregnancy but is
    less comprehensive than CTA/MRA for treatment planning.
  results: Aneurysm morphology, splenic arterial flow, and treatment-access anatomy
  evidence:
  - reference: PMID:1483666
    reference_title: Splenic hyperkinetic state and splenic artery aneurysm in portal hypertension.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The splenic arterial flow was assessed by measuring the radii of the
      splenic arteries on celiac arteriograms.
    explanation: >-
      This supports angiography-based measurement of splenic arterial flow in
      portal-hypertension-associated SAA.
  - reference: PMID:31839799
    reference_title: "Splenic aneurysms: natural history and treatment techniques."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      True aneurysms account for 60% of SAA and affect four times as many women
      as men, generally related to increased incidental or symptomatic findings
      that coincide with use of ultrasonography in pregnancy.
    explanation: >-
      This supports ultrasound as a frequent route to detection in pregnancy.
- name: Post-embolization surveillance imaging
  description: >-
    After coil embolization, follow-up imaging is used to detect sac
    reperfusion, bleeding, or other complications.
  results: Persistent sac perfusion, reperfusion, or post-procedural bleeding
  evidence:
  - reference: PMID:40626033
    reference_title: Imaging modalities used in follow-up after coil embolization of splenic artery aneurysm - a systematic review.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      MRA should be preferred over DSA for detecting aneurysmal sac reperfusion.
    explanation: >-
      This systematic review conclusion supports MRA-based surveillance for sac
      reperfusion after coil embolization.
treatments:
- name: Endovascular coil embolization
  description: >-
    Coil embolization excludes the aneurysm or parent artery from flow and is a
    common first-line approach for intact anatomically suitable SAA.
  treatment_term:
    preferred_term: embolization therapy
    term:
      id: NCIT:C15230
      label: Embolization Therapy
  target_phenotypes:
  - preferred_term: splenic artery aneurysm
    term:
      id: HP:0002617
      label: Vascular dilatation
  target_mechanisms:
  - target: Splenic arterial wall remodeling
    treatment_effect: INHIBITS
    description: Endovascular exclusion reduces flow into the aneurysm sac and mitigates rupture risk.
  evidence:
  - reference: PMID:30496903
    reference_title: Endovascular and Surgical Management of Intact Splenic Artery Aneurysm.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In the endovascular group, the exclusive means was embolization with coils.
    explanation: >-
      The intact-SAA cohort directly describes coil embolization as the
      endovascular approach used.
  - reference: PMID:30496903
    reference_title: Endovascular and Surgical Management of Intact Splenic Artery Aneurysm.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Endovascular repair is less invasive accompanied with an obvious decrease
      in surgery time and rapid recovery with a short hospital time.
    explanation: >-
      The cohort conclusion supports the perioperative recovery advantage of
      endovascular repair.
- name: Open surgical repair, ligation, resection, or splenectomy
  description: >-
    Open repair includes aneurysm ligation or resection, sometimes with
    splenectomy, arterial reconstruction, or distal pancreatic resection,
    especially for rupture, giant lesions, unfavorable anatomy, or instability.
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: MAXO:0000004
      label: surgical procedure
  target_phenotypes:
  - preferred_term: splenic artery aneurysm
    term:
      id: HP:0002617
      label: Vascular dilatation
  target_mechanisms:
  - target: Aneurysm rupture and hemorrhage
    treatment_effect: INHIBITS
    description: Open ligation, resection, and splenectomy control bleeding and remove the aneurysm when rupture or anatomy requires surgery.
  evidence:
  - reference: PMID:30496903
    reference_title: Endovascular and Surgical Management of Intact Splenic Artery Aneurysm.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In the surgical group, the common methods used were splenic artery
      aneurysm resection (9 patients), followed by splenic artery aneurysms
      resection and splenectomy (6 patients), splenic artery aneurysm resection
      and arterial reconstruction with end-to-end anastomosis (3 patients), and
      laparoscopic splenic artery aneurysm resection coexisting with splenectomy
      (2 patients).
    explanation: >-
      The cohort enumerates open/laparoscopic surgical approaches for intact
      SAA.
  - reference: PMID:38249169
    reference_title: Spontaneous Rupture of Splenic Artery Aneurysm.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The patient was submitted to emergency laparotomy with ligation of the
      splenic artery, aneurysm resection, and splenectomy.
    explanation: >-
      This rupture case supports emergency open surgical control with ligation,
      aneurysm resection, and splenectomy.
- name: Selective surveillance of small stable intact true aneurysms
  description: >-
    Selected intact asymptomatic true SAAs can be monitored rather than repaired
    immediately when high-risk features such as childbearing potential,
    symptoms, growth, large size, or pseudoaneurysm are absent.
  treatment_term:
    preferred_term: clinical surveillance
  target_phenotypes:
  - preferred_term: splenic artery aneurysm
    term:
      id: HP:0002617
      label: Vascular dilatation
  evidence:
  - reference: PMID:12089631
    reference_title: "Splenic artery aneurysms: two decades experience at Mayo clinic."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      From analysis of the patient data we concluded that although SAAs may
      rupture, not all intact aneurysms need intervention.
    explanation: >-
      This supports selective nonintervention for carefully selected intact
      aneurysms.
  - reference: PMID:32201007
    reference_title: The Society for Vascular Surgery clinical practice guidelines on the management of visceral aneurysms.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      They include evidence-based size thresholds for repair of aneurysms of the
      renal arteries, splenic artery, celiac artery, and hepatic artery, among
      others.
    explanation: >-
      The SVS guideline abstract supports threshold-based rather than universal
      repair of visceral aneurysms including SAA.
clinical_trials:
- name: NCT07053605
  status: RECRUITING
  description: >-
    Single-group interventional study evaluating laparoscopic resection of SAA
    with spleen preservation and post-treatment immune and portal/splenic
    hemodynamic markers.
  target_phenotypes:
  - preferred_term: splenic artery aneurysm
    term:
      id: HP:0002617
      label: Vascular dilatation
  evidence:
  - reference: clinicaltrials:NCT07053605
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In this study, researchers examined the changes in related indicators such
      as immune function, splenic vein,proper hepatic artery, and portal venous
      hemodynamics following laparoscopic resection of a splenic artery
      aneurysm.
    explanation: >-
      The trial summary directly describes laparoscopic SAA resection with
      spleen preservation and hemodynamic/immune follow-up.
- name: NCT01387828
  status: COMPLETED
  description: >-
    Randomized comparison of open versus laparoscopic surgical management of
    splenic artery aneurysms.
  target_phenotypes:
  - preferred_term: splenic artery aneurysm
    term:
      id: HP:0002617
      label: Vascular dilatation
  evidence:
  - reference: clinicaltrials:NCT01387828
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The purpose of this study is compare two different surgical treatments of
      splenic artery aneurysms: open and laparoscopic approach.
    explanation: >-
      The trial summary supports the existence of a completed open-vs-laparoscopic
      SAA surgical comparison.
notes: >-
  Falcon deep research and PubMed follow-up did not identify a causal gene,
  multi-omics signature, model organism system, or validated quality-of-life
  instrument for isolated splenic artery aneurysm. Portal hypertension,
  pregnancy/childbearing potential, size, symptoms, and growth are the dominant
  actionable risk stratifiers for true SAA. Pseudoaneurysm-specific pancreatitis
  and pseudocyst mechanisms were treated as out of scope for this MONDO true-SAA
  entry.
📚

References & Deep Research

Deep Research

1
Falcon
Splenic Artery Aneurysm (SAA): Comprehensive Disease Characteristics Research Report
Edison Scientific Literature 50 citations 2026-05-06T15:22:42.876213

Splenic Artery Aneurysm (SAA): Comprehensive Disease Characteristics Research Report

Executive summary (current understanding)

Splenic artery aneurysm (SAA) is the most common visceral artery aneurysm and is often incidentally detected; despite a generally low rupture rate for true SAAs, rupture can be catastrophic, with particularly high maternal and fetal mortality in pregnancy. Contemporary expert guidance (SVS 2020; CIRSE 2024) recommends CTA-based diagnosis, aggressive management for pseudoaneurysms (treat regardless of size), and size-/risk-stratified treatment for true SAAs (treat ≥3 cm, symptomatic, enlarging, or in women of childbearing age). Endovascular therapy is generally preferred when anatomically feasible and is associated with lower perioperative morbidity and shorter length of stay, while open surgery remains crucial for rupture, hemodynamic instability, pregnancy-associated rupture, and distal/hilar anatomy. (chaer2020thesocietyfor pages 12-13, chaer2020thesocietyfor pages 13-15, rossi2024cirsestandardsof pages 1-3, hogendoorn2014openrepairendovascular pages 4-5, rinaldi2023endovascularandopen pages 1-3)

Topic Key points Quantitative data Key sources
Disease definition / identifiers / synonyms Splenic artery aneurysm (SAA) is a dilation of the splenic artery; one review defines SAA as arterial dilation >50% of the normal splenic artery diameter. Distinguish true SAA from splenic artery pseudoaneurysm (SAP/SAPA), which has a much higher rupture risk. Common synonyms: splenic artery aneurysm, SAA, true splenic artery aneurysm; pseudoaneurysm terms: splenic artery pseudoaneurysm, SAP. “Giant” SAA is variably defined, most often ≥5 cm, sometimes >10 cm. Giant SAA definition used in literature: ≥5 cm in 62.5% of articles that specified a cutoff; >10 cm in 37.5%. Rinaldi et al., J Clin Med 2024, DOI: 10.3390/jcm13195793, https://doi.org/10.3390/jcm13195793 (2024) (rinaldi2024thedefinitiondiagnosis pages 1-2, rinaldi2024thedefinitiondiagnosis pages 4-6, rinaldi2024thedefinitiondiagnosis pages 7-9)
Epidemiology / frequency SAA is the most common visceral artery aneurysm. Population estimates vary by detection method; frequency has risen with modern imaging. SAAs account for ~60% of visceral/splanchnic aneurysms; reported incidence 0.09% at autopsy and 0.78% on angiography; one older clinical paper cites incidence <0.8%. Rinaldi et al., J Clin Med 2024, DOI: 10.3390/jcm13195793, https://doi.org/10.3390/jcm13195793 (2024); Sticco et al., Vascular 2016, DOI: 10.1177/1708538115613703, https://doi.org/10.1177/1708538115613703 (2016) (rinaldi2024thedefinitiondiagnosis pages 7-9, sticco2016acomparisonof pages 1-2)
Sex / age distribution Classic SAA is more common in women, especially multiparous women; giant SAA series show more balanced sex distribution. Diagnosis is usually in adulthood/midlife. Female predominance reported as ~4:1 for common SAA; giant SAA pooled review: 43 males / 39 females, median age 55.79 years. Obara et al., Surgery Today 2020, DOI: 10.1007/s00595-019-01898-3, https://doi.org/10.1007/s00595-019-01898-3 (2020); Rinaldi et al., J Clin Med 2024, DOI: 10.3390/jcm13195793, https://doi.org/10.3390/jcm13195793 (2024) (obara2020currentmanagementstrategies pages 5-7, rinaldi2024thedefinitiondiagnosis pages 1-2)
Rupture risk and mortality True SAA rupture risk is generally low but clinically important because rupture can be catastrophic. Pseudoaneurysms rupture much more often and are treated regardless of size. Common true SAA rupture risk ~2–3%; older review cites ~3% in more recent series (historically ~10%). Pseudoaneurysm rupture risk reported 37–47%; SVS excerpt cites rupture 76.3% for pseudoaneurysm vs 3.1% for true aneurysm. Ruptured SAA mortality up to ~25% overall; older reports cite rupture mortality up to 30% or 36%. Rinaldi et al., J Clin Med 2024, DOI: 10.3390/jcm13195793, https://doi.org/10.3390/jcm13195793 (2024); Chaer et al., J Vasc Surg 2020, DOI: 10.1016/j.jvs.2020.01.039, https://doi.org/10.1016/j.jvs.2020.01.039 (2020); Obara et al., Surgery Today 2020, DOI: 10.1007/s00595-019-01898-3, https://doi.org/10.1007/s00595-019-01898-3 (2020); Dave et al., Ann Vasc Surg 2000, DOI: 10.1007/s100169910039, https://doi.org/10.1007/s100169910039 (2000) (rinaldi2024thedefinitiondiagnosis pages 7-9, chaer2020thesocietyfor pages 12-13, chaer2020thesocietyfor pages 13-15, obara2020currentmanagementstrategies pages 5-7, dave2000splenicarteryaneurysm pages 4-5, sticco2016acomparisonof pages 1-2)
Pregnancy-associated risk Pregnancy markedly increases rupture risk and is a major reason for aggressive treatment in women of childbearing age. Rupture often occurs in late pregnancy. Pregnancy accounts for ~20–50% of ruptures in older literature/SVS excerpt; maternal mortality ~70–80%; fetal mortality ~90–95%. Chaer et al., J Vasc Surg 2020, DOI: 10.1016/j.jvs.2020.01.039, https://doi.org/10.1016/j.jvs.2020.01.039 (2020); Rinaldi et al., J Clin Med 2024, DOI: 10.3390/jcm13195793, https://doi.org/10.3390/jcm13195793 (2024); Dave et al., Ann Vasc Surg 2000, DOI: 10.1007/s100169910039, https://doi.org/10.1007/s100169910039 (2000) (chaer2020thesocietyfor pages 12-13, rinaldi2024thedefinitiondiagnosis pages 7-9, dave2000splenicarteryaneurysm pages 4-5)
Portal hypertension / liver transplant association Portal hypertension, cirrhosis, and liver transplantation are recurring associations and influence management because of higher rupture/growth concern. Older review: portal hypertension present in up to 24% of SAA patients; incidence in cirrhosis/portal hypertension 7–20%; 8–13% of liver-transplant candidates have SAA. Another review cites 20.5% in liver-transplant recipients. Dave et al., Ann Vasc Surg 2000, DOI: 10.1007/s100169910039, https://doi.org/10.1007/s100169910039 (2000); Obara et al., Surgery Today 2020, DOI: 10.1007/s00595-019-01898-3, https://doi.org/10.1007/s00595-019-01898-3 (2020) (dave2000splenicarteryaneurysm pages 4-5, obara2020currentmanagementstrategies pages 5-7, pratesi2024guidelinesonthe pages 51-53)
Other risk factors / associations Reported associations include multiparity, pancreatitis/pseudocysts, prior surgery, trauma, infection, and nonatherosclerotic arteriopathies such as segmental arterial mediolysis. Pseudoaneurysms are particularly linked to pancreatitis and local inflammatory/surgical injury. Giant SAA/SAP review: pancreatitis/pseudocysts present in 15.85% of pooled giant cases; giant pooled symptoms included pain in 59.76% and asymptomatic presentation in 17.07%. Rinaldi et al., J Clin Med 2024, DOI: 10.3390/jcm13195793, https://doi.org/10.3390/jcm13195793 (2024); Rinaldi et al., J Clin Med 2023, DOI: 10.3390/jcm12186085, https://doi.org/10.3390/jcm12186085 (2023) (rinaldi2024thedefinitiondiagnosis pages 4-6, rinaldi2024thedefinitiondiagnosis pages 9-10, rinaldi2023endovascularandopen pages 1-3)
Clinical presentation Most SAAs are asymptomatic and incidentally discovered, but symptomatic lesions usually present with abdominal or left upper quadrant/epigastric pain. Rupture can cause shock and hemoperitoneum. Older review: 80–95% asymptomatic. Giant pooled series: pain 59.76%, palpable mass 28.05%, asymptomatic 17.07%. Dave et al., Ann Vasc Surg 2000, DOI: 10.1007/s100169910039, https://doi.org/10.1007/s100169910039 (2000); Rinaldi et al., J Clin Med 2024, DOI: 10.3390/jcm13195793, https://doi.org/10.3390/jcm13195793 (2024) (dave2000splenicarteryaneurysm pages 4-5, rinaldi2024thedefinitiondiagnosis pages 4-6, rinaldi2024thedefinitiondiagnosis pages 9-10)
Diagnostic imaging CTA is the preferred initial diagnostic test in most guidelines; MRA is preferred when iodinated contrast is contraindicated and is favored in pregnancy. Angiography is used when planning intervention or when noninvasive imaging is insufficient. Ultrasound/EcoColorDoppler can be first-line screening, but sensitivity for small SAA is limited. CT used in 80.49% of giant pooled cases; selective angiography 54.88%; EcoColorDoppler 45.12%; MRI 3.66%. SVS excerpt notes ultrasound has poor sensitivity for SAA <3 cm. Chaer et al., J Vasc Surg 2020, DOI: 10.1016/j.jvs.2020.01.039, https://doi.org/10.1016/j.jvs.2020.01.039 (2020); Rinaldi et al., J Clin Med 2024, DOI: 10.3390/jcm13195793, https://doi.org/10.3390/jcm13195793 (2024) (chaer2020thesocietyfor pages 12-13, rinaldi2024thedefinitiondiagnosis pages 9-10, rinaldi2024thedefinitiondiagnosis pages 4-6)
SVS 2020 treatment thresholds Treat ruptured SAAs emergently; treat all splenic artery pseudoaneurysms regardless of size; treat all true SAAs in women of childbearing age regardless of size; treat true SAAs that are symptomatic, enlarging, or ≥3 cm. Observation is reasonable for small, stable, asymptomatic true SAAs in non-childbearing patients or those with limited life expectancy. Endovascular therapy is preferred initially when anatomically feasible; open surgery is favored for rupture, pregnancy-related rupture, or distal/hilar lesions. Thresholds: pseudoaneurysm any size; true SAA in women of childbearing age any size; true SAA ≥3 cm; interval growth >0.5 cm/year is an indication. Nonoperative series cited by SVS: mean observed size 2.1 cm, mean follow-up 75 months. Chaer et al., J Vasc Surg 2020, DOI: 10.1016/j.jvs.2020.01.039, https://doi.org/10.1016/j.jvs.2020.01.039 (2020) (chaer2020thesocietyfor pages 13-15, chaer2020thesocietyfor pages 12-13)
CIRSE 2024 thresholds / surveillance Intervene for any symptomatic VAA/VAPA; for SAA specifically, treat asymptomatic lesions ≥2 cm, especially if saccular/distal/favorable anatomy; treat any VAA growing ≥0.5 cm/year; treat VAPAs regardless of symptoms; treat any asymptomatic VAA in women of childbearing age. After endovascular therapy, CTA or MRA surveillance is recommended. Thresholds: SAA ≥2 cm; growth ≥0.5 cm/year. Surveillance after EVT: 3 months, 12 months, then yearly. Rossi et al., Cardiovasc Intervent Radiol 2024, DOI: 10.1007/s00270-023-03620-w, https://doi.org/10.1007/s00270-023-03620-w (2024) (rossi2024cirsestandardsof pages 1-3)
Other 2024 guideline / review excerpts 2024 guidance excerpts broadly support emergency treatment for rupture and symptomatic lesions; observation for stable asymptomatic SAAs <3 cm; intervention for SAAs >3 cm. Some sources advocate treatment at ≥2 cm in pregnant/fertile patients with portal hypertension or those awaiting liver transplant. Usual cutoffs in 2024 excerpts: observe <3 cm if stable; treat >3 cm electively; lesions <2 cm often observed unless rapid growth. Pratesi et al. guideline excerpt (2024) (pratesi2024guidelinesonthe pages 51-53); Rinaldi et al., J Clin Med 2024, DOI: 10.3390/jcm13195793, https://doi.org/10.3390/jcm13195793 (2024) (rinaldi2024thedefinitiondiagnosis pages 9-10)
Endovascular treatment Endovascular therapy is now generally first-line for elective anatomically suitable SAAs. Techniques include coil embolization, sac/parent-artery embolization, plugs, covered stents/stent-grafts, glue/Lipidol, thrombin, stent-assisted coiling. Advantages include shorter length of stay and lower perioperative morbidity; drawbacks include splenic infarction, post-embolization syndrome, and higher reintervention risk in rupture. Giant SAA pooled review: endovascular complication rate 23.08%, mean LOS 2.36 days, no recanalization during median follow-up 17.28 months. Stent-graft review: immediate technical/clinical success 90.2%, splenic infarction 4.9%, aneurysm exclusion 87.8%, no reinterventions. Wang 2024 cohort (63 pts): postembolization syndrome 10 pts; splenic infarction 7 pts; mean LOS 5.5 days; complete thrombosis in all at mean 17.2 months. Rinaldi et al., J Clin Med 2024, DOI: 10.3390/jcm13195793, https://doi.org/10.3390/jcm13195793 (2024); Borghese et al., J Clin Med 2024, DOI: 10.3390/jcm13102802, https://doi.org/10.3390/jcm13102802 (2024); Wang et al., CVIR Endovasc 2024, DOI: 10.1186/s42155-024-00427-9, https://doi.org/10.1186/s42155-024-00427-9 (2024) (rinaldi2024thedefinitiondiagnosis pages 1-2, rinaldi2024thedefinitiondiagnosis pages 6-7)
Open surgery Open repair remains important for ruptured SAAs, hemodynamic instability, pregnancy-associated rupture, and distal/hilar aneurysms where splenic preservation may not be feasible. Procedures include ligation, aneurysmectomy, splenectomy ± distal pancreatectomy, and selective reconstruction. Giant pooled review: open complication rate 14.89%, mean LOS 12.29 days. In nationwide inpatient comparison, open repair had higher cardiac (6.9% vs 2.3%), pulmonary (16.1% vs 8.9%), and SSI (5.1% vs 0.6%) complication rates and longer LOS (6 vs 4 days), with similar in-hospital mortality (3% both) compared with endovascular repair. Rinaldi et al., J Clin Med 2024, DOI: 10.3390/jcm13195793, https://doi.org/10.3390/jcm13195793 (2024); Sticco et al., Vascular 2016, DOI: 10.1177/1708538115613703, https://doi.org/10.1177/1708538115613703 (2016) (rinaldi2024thedefinitiondiagnosis pages 1-2, sticco2016acomparisonof pages 1-2)
Hybrid treatment Hybrid approaches are used selectively for anatomically complex giant lesions. Giant pooled review: hybrid used in 9/82 patients (10.98%), complication rate 22.22%, mean LOS 5 days. Rinaldi et al., J Clin Med 2024, DOI: 10.3390/jcm13195793, https://doi.org/10.3390/jcm13195793 (2024) (rinaldi2024thedefinitiondiagnosis pages 1-2, rinaldi2024thedefinitiondiagnosis pages 6-7)
Comparative outcomes: intact/elective SAA Comparative observational data generally favor endovascular repair for lower perioperative morbidity and shorter hospitalization, while open repair may offer fewer reinterventions/stronger primary technical success in some series. Nationwide inpatient study: LOS 4 vs 6 days (EVT vs open), similar mortality 3% each; lower cardiac/pulmonary/SSI complications with EVT. Mixed VAA/RAA series: LOS 7.2±6.9 vs 11.8±6.7 days in elective cases; primary technical success 79.3% EVT vs 100% open. Sticco et al., Vascular 2016, DOI: 10.1177/1708538115613703, https://doi.org/10.1177/1708538115613703 (2016); Wolk et al., Langenbecks Arch Surg 2021, DOI: 10.1007/s00423-021-02149-1, https://doi.org/10.1007/s00423-021-02149-1 (2021) (sticco2016acomparisonof pages 1-2)
Outcomes in ruptured SAA: open vs EVT For ruptured SAA, available evidence shows similar mortality between open and EVT overall, but EVT has substantially more reinterventions/conversions; open repair remains preferred in hemodynamic instability and pregnancy-related rupture. Systematic review of 350 ruptured SAA patients: overall mortality 10.6%; OSR 12.9% vs EVT 7.8% (p=0.84). Reinterventions after EVT 22.4% (37 total; many converted to laparotomy/splenectomy) vs 1.6% after OSR. Rinaldi et al., J Clin Med 2023, DOI: 10.3390/jcm12186085, https://doi.org/10.3390/jcm12186085 (2023) (rinaldi2023endovascularandopen pages 1-3)

Table: This table summarizes high-yield, evidence-supported facts on splenic artery aneurysm, including epidemiology, major risk factors, imaging, guideline thresholds, and treatment outcomes. It is designed as a compact reference for disease knowledge-base curation and clinical/research synthesis.


1. Disease information

1.1 Overview / definition

  • Definition: A 2024 systematic review defines SAA as “an arterial dilation exceeding 50% of the normal diameter of the splenic artery.” (rinaldi2024thedefinitiondiagnosis pages 6-7)
  • True vs pseudoaneurysm:
  • True SAA involves dilation of the artery with (by definition) the native wall layers; the 2024 review describes progressive degradation of elastic fibers and smooth muscle cells in the wall. (rinaldi2024thedefinitiondiagnosis pages 7-9)
  • Splenic artery pseudoaneurysm (SAP/SAPA) lacks at least one native wall layer and is replaced by fibrotic tissue; it is strongly linked to local arterial injury (pancreatitis/trauma/surgery/infection) and has substantially higher rupture risk. (rinaldi2024thedefinitiondiagnosis pages 7-9, chaer2020thesocietyfor pages 12-13)

1.2 Key identifiers (OMIM/Orphanet/ICD/MeSH/MONDO)

  • Data gap in retrieved corpus: The provided full-text/guideline excerpts did not include explicit OMIM/Orphanet/MeSH/ICD-10/ICD-11/MONDO identifiers. This report therefore cannot cite authoritative codes from the current evidence set.

1.3 Synonyms / alternative names

  • Splenic artery aneurysm; SAA; true splenic artery aneurysm. (rinaldi2024thedefinitiondiagnosis pages 1-2)
  • Splenic artery pseudoaneurysm; SAP; splenic artery false aneurysm (in some surgical literature). (rinaldi2024thedefinitiondiagnosis pages 7-9, chaer2020thesocietyfor pages 13-15)
  • “Giant” SAA/SAP: often defined as ≥5 cm (most common), sometimes >10 cm. (rinaldi2024thedefinitiondiagnosis pages 4-6, rinaldi2024thedefinitiondiagnosis pages 7-9)

1.4 Evidence provenance (individual patients vs aggregated resources)

Most available evidence for SAA derives from aggregated disease-level sources such as guidelines, systematic reviews/meta-analyses, and retrospective series; the rarity and heterogeneity of SAA limit randomized evidence. (marone2023currentdebatesin pages 1-4, hogendoorn2014openrepairendovascular pages 4-5)


2. Etiology

2.1 Disease causal factors (mechanistic)

SAA is a multifactorial vascular disease driven by arterial wall vulnerability and hemodynamic stress.

  • Arterial wall degeneration and stress: An older but influential review attributes SAA formation to degenerative and dysplastic processes (e.g., atherosclerosis/calcification, fibromuscular dysplasia, cystic medial degeneration, myxoid degeneration) coupled with turbulent flow and mechanical injury. (dave2000splenicarteryaneurysm pages 4-5)
  • Portal hypertension/hyperdynamic flow: Portal hypertension creates a “splenic hyperkinetic state” with increased splenic artery flow and diameter; Kóbori et al. link hyperkinetic flow to increased diameter and wall tension “according to the law of Laplace.” (dave2000splenicarteryaneurysm pages 4-5, kobori1997splenicarteryaneurysms pages 3-4)
  • Pregnancy-related hormonal and structural changes: Increased estrogen/progesterone/relaxin (and other pregnancy-associated hormonal factors) are linked to structural weakening (e.g., fragmentation of internal elastic lamina, subendothelial thickening) plus increased third-trimester blood pressure. (rinaldi2024thedefinitiondiagnosis pages 7-9, dave2000splenicarteryaneurysm pages 4-5)
  • Pseudoaneurysm mechanism: Pseudoaneurysms are mainly due to focal wall disruption from pancreatitis/pseudocysts, trauma, surgery, or infection. (rinaldi2024thedefinitiondiagnosis pages 7-9, uy2017vasculardiseasesof pages 4-5)
  • Segmental arterial mediolysis (SAM): A noninflammatory arteriopathy in which “segmental lysis of the tunica media” and smooth muscle loss produce dissecting hematomas and aneurysmal dilatation; portal hypertension may amplify inflow into a pre-existing SAM lesion, precipitating rupture. (lohr2013rapidprogressionof pages 2-3, imai2005berrysplenicartery pages 4-5)

2.2 Risk factors (clinical associations)

  • Portal hypertension / cirrhosis / liver transplantation: consistently associated with higher prevalence and is treated as a high-risk context in guidelines. (chaer2020thesocietyfor pages 12-13, kobori1997splenicarteryaneurysms pages 2-3, kaya2016prevalenceandpredictive pages 1-2)
  • Pregnancy and multiparity: pregnancy is a major rupture-risk setting and drives recommendations to treat all true SAAs in women of childbearing age. (chaer2020thesocietyfor pages 12-13, obara2020currentmanagementstrategies pages 5-7)
  • Pancreatitis / trauma / surgery / infection: particularly for pseudoaneurysm formation. (rinaldi2024thedefinitiondiagnosis pages 7-9, rinaldi2024thedefinitiondiagnosis pages 9-10)
  • Nonatherosclerotic etiologies (e.g., SAM): guideline excerpts list nondegenerative etiologies as reasons for earlier treatment. (chaer2020thesocietyfor pages 13-15)

2.3 Protective factors

  • Data gap: No protective genetic variants or environmental protective factors were identified in the retrieved evidence. One 2024 guideline excerpt notes debate on whether arterial wall calcification is protective, but does not resolve it with quantitative evidence in the excerpt. (pratesi2024guidelinesonthe pages 51-53)

2.4 Gene–environment interactions

  • Data gap: No gene–environment interaction studies were present in the retrieved corpus.

3. Phenotypes

3.1 Core clinical phenotypes (with suggested HPO terms)

A. Asymptomatic/incidental detection (common in non-giant SAAs) * Older review: 80–95% asymptomatic and incidentally found. (dave2000splenicarteryaneurysm pages 4-5) * Giant series differs: only 17.07% asymptomatic. (rinaldi2024thedefinitiondiagnosis pages 4-6) * Suggested HPO: Asymptomatic (HP:0000007).

B. Abdominal pain (most common symptom in giant lesions) * Giant pooled review: pain in 59.76% (left upper quadrant/epigastric common). (rinaldi2024thedefinitiondiagnosis pages 4-6) * Suggested HPO: Abdominal pain (HP:0002027); Left upper quadrant abdominal pain (HP:0025404, if used);

C. Palpable abdominal mass (giant lesions) * Giant pooled review: palpable mass 28.05%. (rinaldi2024thedefinitiondiagnosis pages 4-6) * Suggested HPO: Abdominal mass (HP:0003270).

D. Rupture phenotype: hemorrhage and shock * Ruptured SAA commonly presents with severe abdominal pain, hypotension/hemorrhagic shock, anemia/coagulopathy; emergent CTA used for diagnosis. (rinaldi2023endovascularandopen pages 1-3) * Suggested HPO: Hemorrhagic shock (HP:0001919); Hypotension (HP:0002615); Anemia (HP:0001903).

3.2 Temporal phenotype notes

  • Rupture in pregnancy is most often in third trimester/postpartum in classic series and referenced guideline summaries. (dave2000splenicarteryaneurysm pages 4-5, chaer2020thesocietyfor pages 12-13)

3.3 Quality of life impact

  • Direct QoL instrument data (SF-36/EQ-5D/PROMIS) were not identified in the retrieved sources. Impact is inferred from symptom burden (pain) and catastrophic rupture consequences. (rinaldi2023endovascularandopen pages 1-3, rinaldi2024thedefinitiondiagnosis pages 4-6)

4. Genetic / molecular information

4.1 Causal genes / pathogenic variants

  • Not established for isolated SAA in this evidence set. The retrieved literature emphasizes acquired hemodynamic/hormonal factors and arteriopathies (e.g., SAM) rather than monogenic causation. (rinaldi2024thedefinitiondiagnosis pages 7-9, lohr2013rapidprogressionof pages 2-3)

4.2 Syndromic/associative conditions (non-exhaustive, from retrieved evidence)

Kaya et al. list associated conditions including collagen vascular disease, arteritis, medial fibrodysplasia, and alpha-1 antitrypsin deficiency, but do not provide gene/variant-level data in the excerpt. (kaya2016prevalenceandpredictive pages 5-6)

4.3 Epigenetics / omics

  • Data gap: No epigenomic, transcriptomic, proteomic, or metabolomic signatures were identified in the retrieved corpus.

5. Environmental information

5.1 Environmental, lifestyle, occupational

  • Not specifically characterized for SAA in the retrieved evidence.

5.2 Infectious agents

  • Infection is cited as a potential cause of pseudoaneurysm via arterial wall injury in the 2024 systematic review (as part of SAP etiology), but no organism-specific data are provided. (rinaldi2024thedefinitiondiagnosis pages 7-9)

6. Mechanism / pathophysiology

6.1 Mechanistic causal chains (upstream → downstream)

A. Portal hypertension-associated true SAA 1. Chronic liver disease → portal hypertension → hyperdynamic splanchnic circulation and increased splenic venous flow (“splenic hyperkinetic state”). (dave2000splenicarteryaneurysm pages 4-5) 2. Hyperkinetic splenic arterial flow increases arterial diameter and wall tension (Laplace law) → progressive wall degeneration → aneurysm formation and increased rupture susceptibility. (kobori1997splenicarteryaneurysms pages 3-4, dave2000splenicarteryaneurysm pages 4-5) 3. Clinical manifestation: incidental aneurysm or rupture with hemoperitoneum/shock. (dave2000splenicarteryaneurysm pages 4-5, rinaldi2023endovascularandopen pages 1-3)

B. Pregnancy-associated SAA rupture risk 1. Pregnancy → elevated estrogen/progesterone/relaxin and other hormonal mediators → structural weakening (fragmented internal elastic lamina, subendothelial thickening) and altered elastin integrity. (rinaldi2024thedefinitiondiagnosis pages 7-9, dave2000splenicarteryaneurysm pages 4-5) 2. Concurrent late-pregnancy hemodynamic stress (increased blood volume/cardiac output, increased BP) → increased wall stress → rupture risk. (rinaldi2024thedefinitiondiagnosis pages 7-9)

C. Pancreatitis-associated splenic artery pseudoaneurysm (SAP) 1. Acute/chronic pancreatitis or pseudocyst → enzymatic/inflammatory injury to arterial wall or focal disruption → pseudoaneurysm formation. (rinaldi2024thedefinitiondiagnosis pages 7-9, uy2017vasculardiseasesof pages 4-5) 2. Clinical manifestation: hemorrhage, GI bleeding (e.g., hemosuccus pancreaticus), hemodynamic instability. (obara2020currentmanagementstrategies pages 5-7)

D. Segmental arterial mediolysis (SAM) leading to SAA 1. SAM: segmental medial lysis with smooth muscle loss → gaps/dissecting hematoma → aneurysmal dilation. (lohr2013rapidprogressionof pages 2-3) 2. Superimposed hemodynamic stress (BP surges; portal hypertension increasing inflow) → expansion/rupture. (lohr2013rapidprogressionof pages 2-3, imai2005berrysplenicartery pages 4-5)

6.2 Suggested ontology terms

  • GO biological processes (suggested): blood vessel remodeling; extracellular matrix organization; elastic fiber assembly; response to mechanical stimulus; smooth muscle cell apoptosis; inflammatory response (for pseudoaneurysm etiologies). (rinaldi2024thedefinitiondiagnosis pages 7-9, dave2000splenicarteryaneurysm pages 4-5)
  • Cell types (suggested CL terms): vascular smooth muscle cell; endothelial cell; fibroblast; macrophage (for pancreatitis/injury context). (rinaldi2024thedefinitiondiagnosis pages 7-9, lohr2013rapidprogressionof pages 2-3)

7. Anatomical structures affected

7.1 Primary anatomy (with suggested UBERON terms)

  • Splenic artery (primary affected structure). Suggested UBERON: splenic artery (UBERON:0001621).
  • Spleen: downstream ischemia/infarction risk after embolization or distal ligation. Suggested UBERON: spleen (UBERON:0002106). (chaer2020thesocietyfor pages 13-15)
  • Portal venous system in portal hypertension context; splenic vein enlargement predicts SAA in cirrhosis. Suggested UBERON: splenic vein (UBERON:0001615), portal vein (UBERON:0001633). (kaya2016prevalenceandpredictive pages 1-2)
  • Pancreas: pseudoaneurysm etiologies (pancreatitis), potential erosion/bleeding into pancreatic duct. Suggested UBERON: pancreas (UBERON:0001264). (obara2020currentmanagementstrategies pages 5-7, dave2000splenicarteryaneurysm pages 4-5)

7.2 Tissue/cell and subcellular

  • Primary pathology involves arterial wall layers (intima/media/adventitia), with elastic lamina disruption and smooth muscle cell injury in some pathologic descriptions. (imai2005berrysplenicartery pages 4-5, rinaldi2024thedefinitiondiagnosis pages 7-9)

8. Temporal development

8.1 Onset

  • Typically adult-onset and often detected incidentally due to imaging. (dave2000splenicarteryaneurysm pages 4-5, chaer2020thesocietyfor pages 12-13)

8.2 Progression

  • Many small, stable true SAAs show minimal growth in observed cohorts; SVS excerpt summarizes mean observed size ~2.1 cm with mean follow-up 75 months in a nonoperative Mayo Clinic series. (chaer2020thesocietyfor pages 12-13)

8.3 Critical periods

  • Pregnancy (3rd trimester/postpartum) is a critical risk window for rupture. (dave2000splenicarteryaneurysm pages 4-5, chaer2020thesocietyfor pages 12-13)

9. Inheritance and population

9.1 Epidemiology (general population)

  • Incidence estimates vary by ascertainment method: 0.09% (autopsy) and 0.78% (angiographic) in a 2024 review excerpt. (rinaldi2024thedefinitiondiagnosis pages 7-9)
  • Sticco et al. cite overall incidence <0.8%. (sticco2016acomparisonof pages 1-2)

9.2 Portal hypertension / cirrhosis / transplant populations

  • Liver transplant candidates/recipients: Kóbori et al. (1997) found SAA in 45/337 (13%) liver transplant patients; incidence 16% among those with portal hypertension and 0% without portal hypertension (p<0.001), with higher incidence in adults (17%) vs children (4%). (kobori1997splenicarteryaneurysms pages 2-3)
  • Cirrhosis cohort: Kaya et al. (2016) found SAA in 27/171 (15.7%) cirrhosis patients on four-phase CT; most were distal (74%), solitary (88.8%), and small (mean diameter 11.66 mm). (kaya2016prevalenceandpredictive pages 1-2)

9.3 Sex ratio / age distribution

  • Classic SAA reported female predominance (about 4:1) and association with multiparity; giant SAA systematic review shows near-equal sex distribution. (obara2020currentmanagementstrategies pages 5-7, rinaldi2024thedefinitiondiagnosis pages 1-2)

9.4 Inheritance

  • No Mendelian inheritance pattern is supported by the retrieved evidence for isolated SAA.

10. Diagnostics

10.1 Imaging (core diagnostic modality)

SVS 2020 (key points from excerpt): * CTA recommended as initial diagnostic tool for SAA (thin sections if available). (chaer2020thesocietyfor pages 12-13) * MRA recommended when iodinated contrast is contraindicated; arteriography reserved for unclear noninvasive results or when planning endovascular therapy. (chaer2020thesocietyfor pages 12-13) * Ultrasound has poor sensitivity for SAA <3 cm in SVS excerpt. (chaer2020thesocietyfor pages 12-13)

Giant SAA/SAP imaging patterns (2024 systematic review): CT used in 80.49%, angiography in 54.88%, EcoColorDoppler in 45.12%, MRI rarely (3.66%). (rinaldi2024thedefinitiondiagnosis pages 4-6)

10.2 Laboratory / biomarkers

  • No specific laboratory biomarkers for diagnosis were identified in the retrieved corpus.

10.3 Differential diagnosis

  • Not systematically enumerated in the retrieved excerpts; pseudoaneurysm vs true aneurysm distinction is clinically crucial because pseudoaneurysm rupture risk is much higher. (chaer2020thesocietyfor pages 13-15)

10.4 Screening

  • SVS and related excerpts highlight special high-risk groups (women of childbearing age; portal hypertension/liver transplant candidates), but no population screening program is described in the retrieved evidence. (chaer2020thesocietyfor pages 12-13, chaer2020thesocietyfor pages 13-15)

11. Outcome / prognosis

11.1 Natural history and rupture outcomes

  • True SAA rupture risk is often cited around 2–3%; older and review sources note varying estimates and emphasize risk concentration in pregnancy and portal hypertension contexts. (rinaldi2024thedefinitiondiagnosis pages 7-9, dave2000splenicarteryaneurysm pages 4-5)
  • Ruptured SAA mortality in SVS excerpt: overall mortality up to ~25%. (chaer2020thesocietyfor pages 12-13)

11.2 Pregnancy-related prognosis

  • Pregnancy rupture contributes disproportionately (SVS excerpt: 20–50% of ruptures) and carries extremely high maternal/fetal mortality (e.g., maternal ~80%, fetal ~90% in SVS excerpt; similar ranges across reviews). (chaer2020thesocietyfor pages 12-13, dave2000splenicarteryaneurysm pages 4-5)

11.3 Prognostic factors

  • High-risk contexts: pregnancy, portal hypertension/liver transplantation, pseudoaneurysm etiology, aneurysm growth. (chaer2020thesocietyfor pages 12-13, chaer2020thesocietyfor pages 13-15)

12. Treatment

12.1 Guideline-driven treatment thresholds (expert consensus)

SVS 2020 (Journal of Vascular Surgery; published Jul 2020; DOI: 10.1016/j.jvs.2020.01.039): * Treat ruptured SAA emergently. (chaer2020thesocietyfor pages 12-13) * Treat splenic artery pseudoaneurysms of any size (high rupture risk). (chaer2020thesocietyfor pages 12-13) * Treat all true SAAs in women of childbearing age regardless of size. (chaer2020thesocietyfor pages 12-13) * Treat true SAAs ≥3 cm, those with growth, or those that are symptomatic. (chaer2020thesocietyfor pages 12-13) * Observation suggested for small (<3 cm), stable, asymptomatic true SAAs or patients with limited life expectancy. (chaer2020thesocietyfor pages 12-13)

CIRSE Standards of Practice (Cardiovascular and Interventional Radiology; Nov 2024; DOI: 10.1007/s00270-023-03620-w): * Treat any symptomatic VAA/VAPA; treat SAA ≥2 cm (particularly saccular/distal/favorable anatomy); treat lesions growing ≥0.5 cm/year; treat VAPAs regardless of symptoms; treat asymptomatic VAAs in women of child-bearing age. (rossi2024cirsestandardsof pages 1-3) * Post-endovascular surveillance suggested with CTA/MRA at 3 months, 12 months, then yearly. (rossi2024cirsestandardsof pages 1-3)

Guideline-collision commentary (May 2023; DOI: 10.3390/jcm12093267): * Notes discrepancies across ESVS vs SVS thresholds (e.g., SVS 3 cm threshold for SAA) and differences in surveillance intervals (SVS annual imaging vs ESVS every 2–3 years for small asymptomatic aneurysms). (marone2023currentdebatesin pages 1-4)

12.2 Endovascular treatment (current applications / real-world implementation)

  • SVS and CIRSE emphasize endovascular-first where anatomy allows (coil embolization, parent vessel sacrifice vs preservation strategies, stent-grafts). (chaer2020thesocietyfor pages 13-15, rossi2024cirsestandardsof pages 1-3)
  • Meta-analysis evidence (Hogendoorn 2014; J Vasc Surg; Dec 2014; DOI: 10.1016/j.jvs.2014.08.067):
  • OPEN vs EV: 30-day mortality 5.1% vs 0.6% (P<.001); hospital stay 9.8 vs 2.0 days. (hogendoorn2014openrepairendovascular pages 4-5)
  • EV has more minor complications (post-embolization syndrome treated as minor; ~25.1% in the meta-analysis) and higher reinterventions per year (3.2%/yr EV vs 0.5%/yr open). (hogendoorn2014openrepairendovascular pages 4-5, hogendoorn2014openrepairendovascular pages 8-9)
  • Comparative US inpatient data (Sticco 2016; DOI: 10.1177/1708538115613703) show lower perioperative morbidity and shorter LOS with endovascular repair with similar in-hospital mortality. (sticco2016acomparisonof pages 1-2)

MAXO suggestions (non-exhaustive): * Endovascular embolization procedure; stent-graft placement; aneurysm repair (endovascular). (chaer2020thesocietyfor pages 13-15, rossi2024cirsestandardsof pages 1-3)

12.3 Open surgery

  • Remains essential for rupture, hemodynamic instability, pregnancy-associated rupture, and distal/hilar anatomy. (chaer2020thesocietyfor pages 13-15, rinaldi2023endovascularandopen pages 1-3)

MAXO suggestions: * Aneurysmectomy; arterial ligation; splenectomy; distal pancreatectomy (for select hilar lesions). (rinaldi2024thedefinitiondiagnosis pages 6-7, chaer2020thesocietyfor pages 13-15)

12.4 Treatment outcomes in ruptured SAA

  • Systematic review (J Clin Med; Sep 2023; DOI: 10.3390/jcm12186085): 129 studies/350 patients; overall mortality 10.6%; 12.9% open vs 7.8% EVT (p=0.84); reinterventions 22.4% after EVT vs 1.6% after open repair. (rinaldi2023endovascularandopen pages 1-3)

13. Prevention

13.1 Primary prevention

  • No established primary prevention interventions were identified in the retrieved evidence; prevention focuses on risk recognition (pregnancy/portal hypertension) and addressing modifiable contributors to pancreatitis/trauma when applicable.

13.2 Secondary prevention (surveillance)

  • Surveillance practices vary by guideline; CIRSE suggests CTA/MRA at 3 months, 12 months, then yearly post-EVT. (rossi2024cirsestandardsof pages 1-3)
  • SVS vs ESVS surveillance intervals for small asymptomatic lesions differ (annual vs q2–3 years). (marone2023currentdebatesin pages 1-4)

14. Other species / natural disease

  • Data gap: No veterinary or non-human natural disease evidence was identified in the retrieved corpus.

15. Model organisms

  • Data gap: No model organism systems specific to SAA were identified in the retrieved corpus.

Recent developments and expert analysis (2023–2024 emphasis)

  1. Guideline harmonization and persistent evidence gaps (2023): A 2023 expert commentary highlights how rarity and heterogeneity impede high-level evidence and lead to threshold/surveillance disagreements across SVS vs ESVS, emphasizing the need for careful individualized decision-making. (marone2023currentdebatesin pages 1-4)
  2. Endovascular standardization (2024): CIRSE’s 2024 standards codify endovascular indications, device options, and structured post-procedure surveillance schedules, reflecting the central role of interventional radiology in contemporary care. (rossi2024cirsestandardsof pages 1-3)
  3. Refined characterization of giant SAA/SAP (2024): The 2024 systematic review quantifies presentation patterns, imaging choices (CT predominance), and comparative LOS/complication rates across open/endovascular/hybrid approaches for giant lesions, while underscoring inconsistent “giant” definitions. (rinaldi2024thedefinitiondiagnosis pages 1-2, rinaldi2024thedefinitiondiagnosis pages 4-6)

Clinical trials / research in progress

  • NCT07053605 (ClinicalTrials.gov; first posted 2025-07-08; recruiting): single-group interventional study of laparoscopic resection of SAA with spleen preservation; estimated enrollment 10; start 2025-06-23; primary completion 2027-06-30; primary outcomes emphasize immune function markers (C3/C4, immunoglobulins, lymphocyte subsets) across follow-up timepoints. URL: https://clinicaltrials.gov/study/NCT07053605 (NCT07053605 chunk 1)
  • NCT01387828 (ClinicalTrials.gov; posted 2011; completed): randomized parallel trial comparing open vs laparoscopic splenic aneurysm repair; enrollment 29; start Jan 2001; completion Apr 2011; primary outcome postoperative morbidity (Dindo–Clavien). URL: https://clinicaltrials.gov/study/NCT01387828 (NCT01387828 chunk 1)

Key limitations of this report (evidence availability)

  • Formal MeSH/ICD/ICD-11/MONDO/OMIM/Orphanet identifiers were not present in the retrieved full-text excerpts; therefore, codes are not provided with citations.
  • Genetic variant-level evidence, multi-omics profiling, model organism data, and validated QoL metrics were not found in the retrieved evidence set; the literature here is predominantly clinical and procedural.
  • The report necessarily integrates older landmark sources (e.g., 1997–2000) for portal-hypertension/pregnancy epidemiology because those specific quantitative observations are widely cited and remain foundational; they are contextualized by 2020–2024 guideline syntheses.

References

  1. (chaer2020thesocietyfor pages 12-13): Rabih A. Chaer, Christopher J. Abularrage, Dawn M. Coleman, Mohammad H. Eslami, Vikram S. Kashyap, Caron Rockman, and M. Hassan Murad. The society for vascular surgery clinical practice guidelines on the management of visceral aneurysms. Journal of Vascular Surgery, 72:3S-39S, Jul 2020. URL: https://doi.org/10.1016/j.jvs.2020.01.039, doi:10.1016/j.jvs.2020.01.039. This article has 660 citations and is from a domain leading peer-reviewed journal.

  2. (chaer2020thesocietyfor pages 13-15): Rabih A. Chaer, Christopher J. Abularrage, Dawn M. Coleman, Mohammad H. Eslami, Vikram S. Kashyap, Caron Rockman, and M. Hassan Murad. The society for vascular surgery clinical practice guidelines on the management of visceral aneurysms. Journal of Vascular Surgery, 72:3S-39S, Jul 2020. URL: https://doi.org/10.1016/j.jvs.2020.01.039, doi:10.1016/j.jvs.2020.01.039. This article has 660 citations and is from a domain leading peer-reviewed journal.

  3. (rossi2024cirsestandardsof pages 1-3): Michele Rossi, Miltiadis Krokidis, Elika Kashef, Bora Peynircioglu, and Marcello Andrea Tipaldi. Cirse standards of practice for the endovascular treatment of visceral and renal artery aneurysms and pseudoaneurysms. Cardiovascular and Interventional Radiology, 47:26-35, Nov 2024. URL: https://doi.org/10.1007/s00270-023-03620-w, doi:10.1007/s00270-023-03620-w. This article has 50 citations and is from a peer-reviewed journal.

  4. (hogendoorn2014openrepairendovascular pages 4-5): Wouter Hogendoorn, Anthi Lavida, M.G. Myriam Hunink, Frans L. Moll, George Geroulakos, Bart E. Muhs, and Bauer E. Sumpio. Open repair, endovascular repair, and conservative management of true splenic artery aneurysms. Journal of vascular surgery, 60 6:1667-76.e1, Dec 2014. URL: https://doi.org/10.1016/j.jvs.2014.08.067, doi:10.1016/j.jvs.2014.08.067. This article has 164 citations and is from a domain leading peer-reviewed journal.

  5. (rinaldi2023endovascularandopen pages 1-3): Luigi Federico Rinaldi, Chiara Brioschi, and Enrico Maria Marone. Endovascular and open surgical treatment of ruptured splenic artery aneurysms: a case report and a systematic literature review. Journal of Clinical Medicine, 12:6085, Sep 2023. URL: https://doi.org/10.3390/jcm12186085, doi:10.3390/jcm12186085. This article has 13 citations.

  6. (rinaldi2024thedefinitiondiagnosis pages 1-2): Valerio Rinaldi, Giulio Illuminati, Roberto Caronna, Giampaolo Prezioso, Piergaspare Palumbo, Paolina Saullo, Vito D’Andrea, and Priscilla Nardi. The definition, diagnosis, and management of giant splenic artery aneurysms and pseudoaneurysms: a systematic review. Journal of Clinical Medicine, 13:5793, Sep 2024. URL: https://doi.org/10.3390/jcm13195793, doi:10.3390/jcm13195793. This article has 9 citations.

  7. (rinaldi2024thedefinitiondiagnosis pages 4-6): Valerio Rinaldi, Giulio Illuminati, Roberto Caronna, Giampaolo Prezioso, Piergaspare Palumbo, Paolina Saullo, Vito D’Andrea, and Priscilla Nardi. The definition, diagnosis, and management of giant splenic artery aneurysms and pseudoaneurysms: a systematic review. Journal of Clinical Medicine, 13:5793, Sep 2024. URL: https://doi.org/10.3390/jcm13195793, doi:10.3390/jcm13195793. This article has 9 citations.

  8. (rinaldi2024thedefinitiondiagnosis pages 7-9): Valerio Rinaldi, Giulio Illuminati, Roberto Caronna, Giampaolo Prezioso, Piergaspare Palumbo, Paolina Saullo, Vito D’Andrea, and Priscilla Nardi. The definition, diagnosis, and management of giant splenic artery aneurysms and pseudoaneurysms: a systematic review. Journal of Clinical Medicine, 13:5793, Sep 2024. URL: https://doi.org/10.3390/jcm13195793, doi:10.3390/jcm13195793. This article has 9 citations.

  9. (sticco2016acomparisonof pages 1-2): Andrew Sticco, Alok Aggarwal, Michael D Shapiro, Abimbola Pratt, Donald Rissuci, and Marcus D'ayala. A comparison of open and endovascular treatment strategies for the management of splenic artery aneurysms. Vascular, 24:487-491, Jul 2016. URL: https://doi.org/10.1177/1708538115613703, doi:10.1177/1708538115613703. This article has 17 citations and is from a peer-reviewed journal.

  10. (obara2020currentmanagementstrategies pages 5-7): Hideaki Obara, Matsubara Kentaro, Masanori Inoue, and Yuko Kitagawa. Current management strategies for visceral artery aneurysms: an overview. Surgery Today, 50:38-49, Oct 2020. URL: https://doi.org/10.1007/s00595-019-01898-3, doi:10.1007/s00595-019-01898-3. This article has 123 citations and is from a peer-reviewed journal.

  11. (dave2000splenicarteryaneurysm pages 4-5): Sandeep P. Dave, Ernane D. Reis, Azhar Hossain, Peter J. Taub, Morris D. Kerstein, and Larry H. Hollier. Splenic artery aneurysm in the 1990s. Annals of Vascular Surgery, 14:223-229, May 2000. URL: https://doi.org/10.1007/s100169910039, doi:10.1007/s100169910039. This article has 229 citations and is from a peer-reviewed journal.

  12. (pratesi2024guidelinesonthe pages 51-53): C Pratesi, D Esposito, R Martini, and C Novali. Guidelines on the diagnosis, treatment and management of visceral and renal arteries aneurysms: a joint assessment by the italian societies of vascular and …. Unknown journal, 2024.

  13. (rinaldi2024thedefinitiondiagnosis pages 9-10): Valerio Rinaldi, Giulio Illuminati, Roberto Caronna, Giampaolo Prezioso, Piergaspare Palumbo, Paolina Saullo, Vito D’Andrea, and Priscilla Nardi. The definition, diagnosis, and management of giant splenic artery aneurysms and pseudoaneurysms: a systematic review. Journal of Clinical Medicine, 13:5793, Sep 2024. URL: https://doi.org/10.3390/jcm13195793, doi:10.3390/jcm13195793. This article has 9 citations.

  14. (rinaldi2024thedefinitiondiagnosis pages 6-7): Valerio Rinaldi, Giulio Illuminati, Roberto Caronna, Giampaolo Prezioso, Piergaspare Palumbo, Paolina Saullo, Vito D’Andrea, and Priscilla Nardi. The definition, diagnosis, and management of giant splenic artery aneurysms and pseudoaneurysms: a systematic review. Journal of Clinical Medicine, 13:5793, Sep 2024. URL: https://doi.org/10.3390/jcm13195793, doi:10.3390/jcm13195793. This article has 9 citations.

  15. (marone2023currentdebatesin pages 1-4): Enrico Maria Marone and Luigi Federico Rinaldi. Current debates in the management of visceral artery aneurysms: where the guidelines collide. Journal of Clinical Medicine, 12:3267, May 2023. URL: https://doi.org/10.3390/jcm12093267, doi:10.3390/jcm12093267. This article has 7 citations.

  16. (kobori1997splenicarteryaneurysms pages 3-4): László Kóbori, Marjan J. van der Kolk, Koert P. de Jong, Paul M.J.G. Peeters, Ids J. Klompmaker, Theo Kok, Elizabeth B. Haagsma, and Maarten J.H. Slooff. Splenic artery aneurysms in liver transplant patients. Journal of Hepatology, 27:890-893, Nov 1997. URL: https://doi.org/10.1016/s0168-8278(97)80327-3, doi:10.1016/s0168-8278(97)80327-3. This article has 68 citations and is from a highest quality peer-reviewed journal.

  17. (uy2017vasculardiseasesof pages 4-5): Pearl Princess D. Uy, Denise Marie Francisco, Anshu Trivedi, Michael O’Loughlin, and George Y. Wu. Vascular diseases of the spleen: a review. Journal of Clinical and Translational Hepatology, 5:152-164, Mar 2017. URL: https://doi.org/10.14218/jcth.2016.00062, doi:10.14218/jcth.2016.00062. This article has 67 citations.

  18. (lohr2013rapidprogressionof pages 2-3): J.-Matthias Löhr, Dietmar Dinter, Steffen J. Diehl, Stephan L. Haas, Mira Veeser, Roland Pfützer, Jürgen Retter, Stefan O. Schönberg, Christoph Düber, Volker Keim, Dirk Schadendorf, and Heiko Witt. Rapid progression of a splenic aneurysm due to segmental arterial mediolysis: a rare cause of acute pancreatitis. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 13 5:553-6, Sep 2013. URL: https://doi.org/10.1016/j.pan.2013.06.001, doi:10.1016/j.pan.2013.06.001. This article has 5 citations.

  19. (imai2005berrysplenicartery pages 4-5): Miwa Akasofu Imai, Ei Kawahara, Shogo Katsuda, and Tatsuya Yamashita. Berry splenic artery aneurysm rupture in association with segmental arterial mediolysis and portal hypertension. Pathology International, 55:290-295, May 2005. URL: https://doi.org/10.1111/j.1440-1827.2005.01827.x, doi:10.1111/j.1440-1827.2005.01827.x. This article has 16 citations and is from a peer-reviewed journal.

  20. (kobori1997splenicarteryaneurysms pages 2-3): László Kóbori, Marjan J. van der Kolk, Koert P. de Jong, Paul M.J.G. Peeters, Ids J. Klompmaker, Theo Kok, Elizabeth B. Haagsma, and Maarten J.H. Slooff. Splenic artery aneurysms in liver transplant patients. Journal of Hepatology, 27:890-893, Nov 1997. URL: https://doi.org/10.1016/s0168-8278(97)80327-3, doi:10.1016/s0168-8278(97)80327-3. This article has 68 citations and is from a highest quality peer-reviewed journal.

  21. (kaya2016prevalenceandpredictive pages 1-2): Muhsin Kaya, Şengül Baran, Cemil Güya, and Mehmet Ali Kaplan. Prevalence and predictive factors for development of splenic artery aneurysms in cirrhosis. Indian Journal of Gastroenterology, 35:201-206, Jun 2016. URL: https://doi.org/10.1007/s12664-016-0670-z, doi:10.1007/s12664-016-0670-z. This article has 21 citations and is from a peer-reviewed journal.

  22. (kaya2016prevalenceandpredictive pages 5-6): Muhsin Kaya, Şengül Baran, Cemil Güya, and Mehmet Ali Kaplan. Prevalence and predictive factors for development of splenic artery aneurysms in cirrhosis. Indian Journal of Gastroenterology, 35:201-206, Jun 2016. URL: https://doi.org/10.1007/s12664-016-0670-z, doi:10.1007/s12664-016-0670-z. This article has 21 citations and is from a peer-reviewed journal.

  23. (hogendoorn2014openrepairendovascular pages 8-9): Wouter Hogendoorn, Anthi Lavida, M.G. Myriam Hunink, Frans L. Moll, George Geroulakos, Bart E. Muhs, and Bauer E. Sumpio. Open repair, endovascular repair, and conservative management of true splenic artery aneurysms. Journal of vascular surgery, 60 6:1667-76.e1, Dec 2014. URL: https://doi.org/10.1016/j.jvs.2014.08.067, doi:10.1016/j.jvs.2014.08.067. This article has 164 citations and is from a domain leading peer-reviewed journal.

  24. (NCT07053605 chunk 1): Guo-Qing Jiang. Clinical Study on Laparoscopic Resection of Splenic Artery Aneurysm With Preservation of Spleen. Northern Jiangsu People's Hospital. 2025. ClinicalTrials.gov Identifier: NCT07053605

  25. (NCT01387828 chunk 1): Comparison Between Open and Laparoscopic Splenic Aneurysms Repair. Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia. 2001. ClinicalTrials.gov Identifier: NCT01387828